Swaminathan Neeraja, Varadi Gabor
Internal Medicine, Albert Einstein Medical Center, Philadelphia, USA.
Hematology and Oncology, Albert Einstein Medical Center, Philadelphia, USA.
Cureus. 2020 Jun 19;12(6):e8693. doi: 10.7759/cureus.8693.
Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma and has a poor prognosis. It needs prompt recognition in order to institute timely treatment. Given its relatively low incidence, it is an evolving area of research as well. This case report describes a patient with PCL in the setting of a previously treated myeloma. The report also reviews the clinicopathologic, cytogenetic, and immunophenotypic characteristics of PCL and its management.
浆细胞白血病(PCL)是骨髓瘤的一种罕见且侵袭性强的变异型,预后较差。需要迅速识别以便及时进行治疗。鉴于其发病率相对较低,它也是一个不断发展的研究领域。本病例报告描述了一名在既往接受过治疗的骨髓瘤背景下发生PCL的患者。该报告还回顾了PCL的临床病理、细胞遗传学和免疫表型特征及其治疗。